
GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

